Beyond the Knudson's hypothesis in von Hippel-Lindau (VHL) disease-proposing vitronectin as a "gene modifier"

Journal of Molecular Medicine

Volumn 87, Issue 6, 2009, Pages 591-593

  Turturro, Francesco ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITRONECTIN;

ANGIOGENESIS; ARTICLE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; HEMANGIOBLASTOMA; HUMAN; VHL GENE; VON HIPPEL LINDAU DISEASE;

HUMANS; MODELS, BIOLOGICAL; VITRONECTIN; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 67349227173     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0466-z     Document Type: Article

References (16)

1. JA Butman WM Linehan RR Lonser 2008 Neurologic manifestations of von Hippel-Lindau disease JAMA 300 1334 1342
2. RR Lonser GM Glenn M Walther EY Chew SK Libutti WM Linehan EH Oldfield 2003 Von Hippel-Lindau disease Lancet 361 2059 2067 (Pubitemid 36695052)
3. F Latif K Tory J Gnara M Yao FM Duh ML Orcutt T Stackhouse I Kuzmin W Modi L Geil 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1317 1320
4. WY Kim WG Kaelin 2004 Role of VHL gene mutation in human cancer J Clin Oncol 22 4991 5004 (Pubitemid 46646218)
5. AGJ Knudson 1986 Genetics of human cancer Ann Rev Genet 20 231 251
6. C Stolle G Gleen B Zbar JS Humphrey P Choyke M Walther S Pack K Hurley C Andrey R Klausner WM Linehan 1998 Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene Hum Mutat 12 417 423 (Pubitemid 28512618)
7. MT Sgambati C Stolle PL Choyke MM Walther B Zbar WM Linehan GM Glenn 2000 Mosaicism in von Hippel-Lindau disease: lessons from kindred's with germline mutations identified in offspring with mosaic parents Am J Hum Genet 66 84 91 (Pubitemid 30481470)
8. JE Wanebo RR Lonser GM Glenn EH Oldfield 2003 The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease J Neurosurg 98 82 94 (Pubitemid 36050451)
9. M Ohh R Yauch KM Lonergan JM Whaley AO Stemmer-Rachamimov DN Louis BJ Gavin N Kley WG Kaelin O Iliopoulos 1998 The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix Mol Cell 1 959 968 (Pubitemid 128379257)
10. EJ Davidowitz AR Schoenfeld RD Burk 2001 VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling Mol Cell Biol 21 865 874 (Pubitemid 32104734)
11. AR Webster FM Richards FE MacRonald AT Moore ER Maher 1998 An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifiers effects Am J Hum Gen 63 1025 1035 (Pubitemid 30418572)
12. JS Huang CM Lin YC Cheng KL Hung CC Chien SK Chen CJ Chang CW Chen CJ Huang 2009 A vitronectin M381 polymorphism increases the risk of hemangioblastoma in patients with VHL gene defect J Mol Med 10.1007/s00109-009- 0456-1
13. K Kubota M Hayashi N Oishi Y Sakaki 1990 Polymorphism of the human vitronectin gene causes vitronectin blood type Biochem Biophys Res Commun 167 1355 1360 (Pubitemid 20113330)
14. R Silva G D'Amico KM Hodivala-Dilke LE Reynolds 2008 Integrins, the key to unlocking angiogenesis Arterioscler Thromb Vasc Biol 28 1703 1713
15. 5 and the ratio of eukaryotic initiation factor 4E (eif4E)/phosphorylated 4E-binding protein 1 (4EBP-1) level in hematopoietic derived cell lines Proc Am Assoc Cancer Res 45 #3235
16. ME Cockman N Masson DR Mole P Jaakkola GW Chang SC Clifford ER Maher CW Pugh PJ Ratclife PH Maxwell 2000 Hypoxia-inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 25733 25741